AGL 38.00 No Change ▼ 0.00 (0%)
AIRLINK 215.50 Increased By ▲ 5.12 (2.43%)
BOP 9.37 Decreased By ▼ -0.11 (-1.16%)
CNERGY 6.32 Decreased By ▼ -0.16 (-2.47%)
DCL 8.84 Decreased By ▼ -0.12 (-1.34%)
DFML 42.21 Increased By ▲ 3.84 (10.01%)
DGKC 94.19 Decreased By ▼ -2.73 (-2.82%)
FCCL 35.20 Decreased By ▼ -1.20 (-3.3%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 16.45 Increased By ▲ 1.50 (10.03%)
HUBC 127.13 Decreased By ▼ -3.56 (-2.72%)
HUMNL 13.50 Increased By ▲ 0.21 (1.58%)
KEL 5.31 Decreased By ▼ -0.19 (-3.45%)
KOSM 6.97 Increased By ▲ 0.04 (0.58%)
MLCF 43.00 Decreased By ▼ -1.78 (-3.97%)
NBP 58.96 Decreased By ▼ -0.11 (-0.19%)
OGDC 217.99 Decreased By ▼ -12.14 (-5.28%)
PAEL 39.39 Increased By ▲ 0.10 (0.25%)
PIBTL 8.25 Decreased By ▼ -0.06 (-0.72%)
PPL 190.50 Decreased By ▼ -9.85 (-4.92%)
PRL 37.85 Decreased By ▼ -1.03 (-2.65%)
PTC 26.30 Decreased By ▼ -0.58 (-2.16%)
SEARL 103.60 Decreased By ▼ -0.03 (-0.03%)
TELE 8.45 No Change ▼ 0.00 (0%)
TOMCL 34.75 Decreased By ▼ -0.50 (-1.42%)
TPLP 12.98 Decreased By ▼ -0.54 (-3.99%)
TREET 25.50 Increased By ▲ 0.49 (1.96%)
TRG 70.53 Increased By ▲ 6.41 (10%)
UNITY 33.37 Decreased By ▼ -1.15 (-3.33%)
WTL 1.72 Decreased By ▼ -0.06 (-3.37%)
BR100 11,881 Decreased By -216 (-1.79%)
BR30 36,807 Decreased By -908.3 (-2.41%)
KSE100 110,423 Decreased By -1991.5 (-1.77%)
KSE30 34,778 Decreased By -730.1 (-2.06%)
Business & Finance

Moderna to deliver 25 million COVID-19 vaccine doses to Australia

  • It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.
  • The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.
Published May 12, 2021

Moderna Inc will supply Australia 25 million doses of its COVID-19 vaccine, of which 10 million doses against the original strain of the virus will be delivered this year, the drugmaker said on Wednesday.

Australia currently has two authorized vaccines from Pfizer-BioNTech and AstraZeneca.

It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.

The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.

The pact with Moderna is subject to regulatory approval of its vaccine candidate, which is authorized for emergency use in individuals 18 years of age or older in the United States.

Moderna has also received authorization for its vaccine from health agencies including Canada, Israel, the European Union, the United Kingdom and Switzerland.

Comments

Comments are closed.